Zenicor Medical Financials
ZENI Stock | SEK 1.77 0.00 0.00% |
Zenicor |
Understanding current and past Zenicor Medical Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Zenicor Medical's financial statements are interrelated, with each one affecting the others. For example, an increase in Zenicor Medical's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Zenicor Medical's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Zenicor Medical Systems. Check Zenicor Medical's Beneish M Score to see the likelihood of Zenicor Medical's management manipulating its earnings.
Instrument | Sweden Stock View All |
Exchange | Stockholm Exchange |
Benchmark | Dow Jones Industrial |
Currency | SEK - Swedish Kronor |
Zenicor Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Zenicor Medical's current stock value. Our valuation model uses many indicators to compare Zenicor Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Zenicor Medical competition to find correlations between indicators driving Zenicor Medical's intrinsic value. More Info.Zenicor Medical Systems is rated first in ebitda category among its peers. It is rated below average in total asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Zenicor Medical's earnings, one of the primary drivers of an investment's value.Zenicor Medical Systems Systematic Risk
Zenicor Medical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Zenicor Medical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Zenicor Medical Systems correlated with the market. If Beta is less than 0 Zenicor Medical generally moves in the opposite direction as compared to the market. If Zenicor Medical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Zenicor Medical Systems is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Zenicor Medical is generally in the same direction as the market. If Beta > 1 Zenicor Medical moves generally in the same direction as, but more than the movement of the benchmark.
Zenicor Medical Thematic Clasifications
Zenicor Medical Systems is part of Drugs investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery
This theme covers Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery. Get More Thematic Ideas
Drugs | View |
Zenicor Medical January 7, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Zenicor Medical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Zenicor Medical Systems. We use our internally-developed statistical techniques to arrive at the intrinsic value of Zenicor Medical Systems based on widely used predictive technical indicators. In general, we focus on analyzing Zenicor Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Zenicor Medical's daily price indicators and compare them against related drivers.
Information Ratio | (0.02) | |||
Maximum Drawdown | 23.1 | |||
Value At Risk | (7.41) | |||
Potential Upside | 10.05 |
Additional Tools for Zenicor Stock Analysis
When running Zenicor Medical's price analysis, check to measure Zenicor Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zenicor Medical is operating at the current time. Most of Zenicor Medical's value examination focuses on studying past and present price action to predict the probability of Zenicor Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zenicor Medical's price. Additionally, you may evaluate how the addition of Zenicor Medical to your portfolios can decrease your overall portfolio volatility.